CIAPIN1 and gastric cancer: This result reinforces the prognosis value of these genes for GC, with high sensitivity (92.3% for UXT and 93.3% for CIAPIN1), and specificity (90.7% for UXT and 96.2% for CIAPIN1) in the ROC curve.